Project programme
|
|
|
|
EFA projects
|
835269,06 |
|
|
| |
Atopic Eczema Consensus Europe Abbvie |
41.433,33 |
5% |
3,98% |
| |
Atopic Eczema Consensus Europe LeoPharma |
41.433,33 |
5% |
3,98% |
| |
Atopic Eczema Consensus Europe Sanofi/Regeneron |
41.433,33 |
5% |
3,98% |
| |
Atopic Eczema Deferred Income from 2020 |
5.000 |
1% |
0,48% |
| |
Breathe Coalition Astra Zeneca |
29.920 |
4% |
2,87% |
| |
Breathe Coalition Chiesi |
29.920 |
4% |
2,87% |
| |
Breathe Coalition BI |
29.920 |
4% |
2,87% |
| |
Breathe Coalition GSK |
29.920 |
4% |
2,87% |
| |
Breathe Coalition Roche |
29.920 |
4% |
2,87% |
| |
Breathe Coalition Deferred Income from 2020 |
5.000 |
1% |
0,48% |
| |
Capacity Bulding Astra Zeneca |
38.225 |
5% |
3,67% |
| |
Capacity Building Chiesi |
25.483,33 |
3% |
2,45% |
| |
Capacity Building Novartis |
25.483,33 |
3% |
2,45% |
| |
Capcity Building Deferred income from 2020 |
5.000 |
1% |
0,48% |
| |
DIGIT Astra Zeneca |
76.371,4 |
9% |
7,33% |
| |
DIGIT Chiesi |
76.371,5 |
9% |
7,33% |
| |
DIGIT MSD |
76.371,5 |
9% |
7,33% |
| |
DIGIT OM Pharma |
76.371,5 |
9% |
7,33% |
| |
DIGIT Roche |
76.371,5 |
9% |
7,33% |
| |
Digit Deferred Income from 2020 |
25.000 |
3% |
2,40% |
| |
Interest Group Chiesi |
15.106,67 |
2% |
1,45% |
| |
Interest Group GSK |
15.106,67 |
2% |
1,45% |
| |
Interest Group Sanofi/Regeneron |
15.106,67 |
2% |
1,45% |
| |
Interest Group Deferred Income from 2020 |
5.000 |
1% |
0,48% |
| |
Deferred income 2021 to EFA Projects 2022 |
-169.076,37 |
|
|
EU projects
|
16.830,26 |
|
|
| |
3TR |
4.549,52 |
27% |
0,44% |
| |
CURE |
9.234,38 |
55% |
0,89% |
| |
Immuniverse |
3.046,36 |
18% |
0,29% |